Pathstone Holdings, LLC

Position in ABOS — Acumen Pharmaceuticals, Inc.

CIK 2011612 ENGLEWOOD, NJ

Position in ABOS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$2,027,499

+$214,777 QoQ

Shares Held

859,110

0.0% QoQ

Ownership

1.19%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#11

of 84 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pathstone Holdings, LLC holds $81,066,919 across 49 Biotechnology names. ABOS ranks #13 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	44,262	$19,764,751
2	REGN	Regeneron Pharmaceuticals, Inc.	15,912	$12,294,246
3	INSM	INSMED Inc	27,249	$4,455,756
4	PTGX	Protagonist Therapeutics, Inc	28,252	$2,977,760
5	CYTK	Cytokinetics Inc	44,516	$2,934,049
6	MDGL	Madrigal Pharmaceuticals, Inc.	5,457	$2,856,575
7	JAZZ	Jazz Pharmaceuticals plc	13,947	$2,636,679
8	IONS	Ionis Pharmaceuticals Inc	32,835	$2,465,579

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,027,499	859,110	0.0%	Shares	Sole	2026-05-11
2025-12-31	$1,812,722	859,110	0.0%	Shares	Sole	2026-02-13
2025-09-30	$1,469,078	859,110	-18.8%	Shares	Sole	2025-11-13
2025-06-30	$1,227,895	1,058,531	-2.6%	Shares	Sole	2025-08-12
2025-03-31	$1,195,184	1,086,531	+79.0%	Shares	Sole	2025-05-15
2024-12-31	$1,043,772	606,845	+17.3%	Shares	Sole	2025-02-14
2024-09-30	$1,282,861	517,283	+7.7%	Shares	Sole	2024-11-07
2024-06-30	$1,162,138	480,223	+0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,944,732	480,181	+0.2%	Shares	Sole	2024-05-13
2023-12-31	$1,839,931	479,149	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.